Roche says Avastin slows brain cancer tumor growth

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said a new study of cancer drug Avastin showed it significantly extended progression-free survival of people with an aggressive form of brain cancer.

symptoms of clots